ArticleMaterials today (Kidlington, England)

Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier.

Zhuoya Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.